Solana

Solana EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Solana (HSDT) as of Oct 16, 2026 is -13.24 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -392.52 % — a change of -96.63% (higher).

EBIT/Assets

-13.24 %

YoY

-96.63%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Solana is 2025 -13.24 % . Operating Income to Assets Ratio (EBIT/Assets) of Solana was 2024 -392.52 % . It decreases by -96.63% higher compared to the previous year.

The Solana EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-95.86 USD
Jan 1, 2019
-231.91 USD
Jan 1, 2020
-215.00 USD
Jan 1, 2021
-128.65 USD
Jan 1, 2022
-89.76 USD
Jan 1, 2023
-161.57 USD
Jan 1, 2024
-392.52 USD
Jan 1, 2025
-13.24 USD
The Solana EBIT/Assets history
YEAREBIT/AssetsYoY
-13.24 %-96.63%
-392.52 %+142.94%
-161.57 %+80.01%
-89.76 %-30.23%
-128.65 %-40.16%
-215.00 %-7.29%
-231.91 %+141.93%
-95.86 %-76.71%
-411.57 %+78.49%
-230.59 %+0.00%
-230.59 %-71.40%
-806.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solana Stock analysis

What does Solana do? Solana Co, with ticker HSDT and ISIN US42328V8761, is a health care company based in Newtown, United States. The company has 21 employees and went public on June 27, 2014. Its website is https://heliusmedical.com/. Solana Co operates within the health care sector, focusing on neurological wellness through non-invasive medical technologies. The company develops, licenses, or acquires non-invasive platform technologies designed to enhance the brain's natural healing capabilities. While the source description mentions a product called the portable neuromodulation stimulator (PoNS) device, which is described as a class II medical device in Canada for treating balance deficits related to mild-to-moderate traumatic brain injury, Solana Co's profile does not confirm this product or its specific applications. The company's operations and product details are not elaborated beyond the provided information. Solana Co is headquartered in Newtown, Pennsylvania, and its primary focus remains on neurological wellness within the health care industry. The company's public listing date and employee count are the only financial and operational details available in the provided data. No additional acquisitions, founding year, or specific product names beyond the general description are confirmed in the factual information provided. Solana is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Solana stock

Operating Income to Assets Ratio (EBIT/Assets) of Solana is -13.24 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Solana changed from -392.52 % to -13.24 %, representing a -96.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Solana since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Solana with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Solana

All Key Metrics — Solana